Objective: This study aimed to reveal the relationships between histologic grade and other clinicopathologic parameters including intrinsic subtype in Taiwanese women with breast cancer. Methods: There were 1302 women diagnosed with breast cancer recruited for this study. Histologic grade was scored according to the Nottingham-modified Bloom -Richardson grading system. Results: Higher tumor grade was associated with larger tumor size (P ¼ 0.021), a larger number of lymph node metastases (P ¼ 0.001), advanced clinical stage (P ¼ 0.010), higher human epithelial growth receptor-2 positivity (P , 0.001), negative estrogen receptor and progesterone receptor (P , 0.0001) status. Triple negative breast cancer (56.6%) and human epithelial growth receptor-2 (44.3%) subtypes were associated with more Grade III breast cancer in contrast to luminal A (22.3%) and B (29.9%) breast cancer. In multivariate Cox regression analysis for cancer-specific survival, histologic grade (hazard ratio ¼ 1.78) was a significant prognostic factor. Conclusions: This study demonstrated that histologic grade is highly correlated with some valuable biomarkers and confirmed the significance of histologic grade in Taiwanese female breast cancers.
INTRODUCTION
Breast cancer is heterogeneous (1 -3) , and even the same histologic subtype can be present with different potentials for disease recurrence and distant metastasis. To identify those who may suffer from recurrence, ideal prognostic factors are very important to predict patients who would benefit from adjuvant treatment or do well without further chemotherapy and be spared the adverse side effects. Currently, tumor size, lymph node status and histologic grade are the three most powerful prognostic factors recognized internationally in clinical practice (4).
The current most widely used histologic grade is the Bloom -Richardson (B -R) scoring system (5) or the Nottingham modification of the B -R score (6) . The concept of histologic grading was originated in 1925 by Greenough (7) , who first proposed quantifying a combination of tubule formation (cellular differentiation), nuclear pleomorphism and hyperchromatism ( proliferation potential) to stratify the degree of malignancy. Nowadays, histologic grade is included in the standard pathologic report of breast cancer in many countries and organizations (8 -11) . The value of the B -R score and Nottingham grading system has been confirmed in many trials and studies (1,2,4 -6,12-17) . However, most of them involved Caucasian women and reported decades ago. Only rarely have studies with a large cohort shown the significance of tumor grade in breast cancer in Asian women (18) . Furthermore, recent development of molecular biology and microarray had identified breast cancer subsets with distinct biology (19 -22) . The association between histologic grade and intrinsic subtype deserves further investigation.
This study aimed to clarify the correlation among histologic grade, intrinsic subtypes and clinicopathologic features in Asian women and its impact on survival in the 21th century.
PATIENTS AND METHODS
Data used were derived from the databases of the cancer registry for women with breast cancer who were diagnosed between 2002 and 2006 at Changhua Christian Hospital (CCH). This study had been approved by the institutional review board of CCH, Taiwan. The data collected included demographic features, tumor characteristics and biological subtype. Tumor size used here was based on the largest diameter of the invasive component of breast tumor specimen recorded in the pathology reports. Staging in this study was based on the American Joint Committee on Cancer staging group's Cancer Staging Manual, 6th edition (23) . Disease-free survival (DFS) was defined as freedom from breast cancer recurrence or breast cancer death. Cancer-specific survival (CSS) was defined as freedom from breast cancer death. Total incidences of recurrence or death from breast cancer were ascertained from follow-up lasting until 31 December 2007.
HISTOLOGIC GRADE
Histologic grade was scored according to the Nottingham modification of the B -R histologic grading system (6) . Tumors were graded independently by two experienced pathologists who obtained over 90% agreement on the first assessment. The Nottingham grading system is based on a microscopic evaluation of morphologic and cytologic features of tumor cells, including degree of tubule formation, nuclear pleomorphism and mitotic count (6) . The sum of these scores stratifies breast tumors into Grade I (score 3 -5, well-differentiated), Grade II (6 -7, moderately differentiated) and Grade III (8 -9, poorly differentiated) malignancies.
IMMUNOHISTOCHEMISTRY
Estrogen receptor (ER), progesterone receptor (PR) and human epithelial growth receptor-2 (HER-2) status determined by the immunohistochemistry (IHC) method were the basic reported items in our pathologic record. IHC analysis was performed on formalin-fixed, paraffin-embedded breast cancer tissue. The ER and PR analyses based on an IHC assay, in which a report of 10% or greater of cells that had nuclear staining for ER, as well as for PR, was considered a positive result. IHC was performed with anti-ER (NeoMarkers, clone: SP1, dilution: 1:200, Fremont, CA) and anti-PR antibodies (NeoMarkers, clone: SP2, dilution: 1:250) using an autostaining system (Ventana Medical Systems, Tucson, AZ).
HER-2 IHC used only cell-membrane localization for interpretation (Dako, Carpinteria, CA). The intensity of the membrane staining was defined using a semi-quantitative score (0 -3þ). Tumor staining was compared with the staining of normal breast epithelium from the same patient as a negative control. For clinical purposes, 3þ staining, defined as uniform and intense membrane staining in .30% of invasive breast cancer cells, was considered HER-2 overexpression. No staining or weak (1þ) and incomplete membrane staining was considered a negative result. Patients with 2 þ IHC staining of HER-2 underwent fluorescence in situ hybridization to confirm HER-2 positivity.
DEFINITION OF TUMOR INTRINSIC SUBTYPE
The intrinsic tumor subtypes used here was a classification according to the IHC staining of ER, PR and HER-2/neu status (24, 25) . Luminal A breast cancer was defined as ER positive and/or PR positive and HER-2 negative. Luminal B breast cancer was defined as ER positive and/or PR positive and HER-2 positive. HER-2 subtype of breast tumor was defined as ER negative, PR negative and HER-2 positive. Triple negative breast cancer (TNBC) was defined as ER negative, PR negative and HER-2 negative.
STATISTICS
For the statistical analysis, one-way ANOVA was used to test the differences among different grading groups and the chisquare test was used to test the comparison of categorical variables when appropriate. In addition, small numbers counted in categorical variables, e.g. staging, were analyzed by the Fisher's exact test. The statistically significant level was considered when the P value was ,0.05. The Kaplan -Meier survival analysis was used for estimating the cumulative DFS and CSS of breast cancer patients. The differences in cumulative survival were assessed by using the log-rank test.
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The role of histologic grade in breast cancer Table 1 . According to the Nottingham modification of the B -R grading system, 59 (5.2%) patients had Grade I breast cancer, 720 (63.5%) Grade II and 355 (31.3%) Grade III. Tumor histologic grade was not associated with age (P ¼ 0.87), and larger tumor size was associated with higher tumor grade (P ¼ 0.021). Higher histologic grade was associated with more positive lymph node metastasis (P ¼ 0.001). No statistically significant association between distant metastasis at presentation and histologic grade was found (P ¼ 0.329). Stage of disease at diagnosis was highly associated with histologic grade (P ¼ 0.010). Tumor histologic grade was associated with a higher chemotherapy ratio (P ¼ 0.0005) and higher incidence of breast cancer death (P ¼ 0.0017). Higher histologic grade was associated with a higher HER-2 expression ratio and inversely associated with ER and PR status (P , 0.0001). The association between clinicopathologic parameters and tumor grade is summarized in Table 2 .
RESULTS
Among 1044 patients whose tumor intrinsic subtype could be deduced from IHC staining, 167 (16%) had TNBC, 97 (9.3%) HER-2 type, 620 (59.4%) luminal A and 160 (15.3%) luminal B. TNBC was associated with the most frequent Grade III tumor (56.6%), followed by HER-2 type (44.3%), then luminal B (29.9%) and luminal A (22.3%; P , 0.0001). The association between intrinsic subtype and tumor grade is showed in Table 3 .
In univariate Cox regression model analysis for 5-year cumulative CSS, age [hazard ratio (HR) ¼ Table 4 . DFS and CSS in the TNM staging system, intrinsic subtype and B-R score grading system are shown in Fig. 1 . Histologic grade of the breast cancer was highly associated with patients' survival and prognosis in Taiwanese women. In both DFS (recurrence-free interval) and CSS, Grade I was associated with the most favorable prognosis and Grade III had the worst. Cumulative DFS and CSS were evidently differentiated with Grades I, II and III (P ¼ 0.0002 and 0.002 separately, by log-rank test; Fig. 1E and F). Compared with low Grade (I þ II) breast cancer, high Grade (III) breast cancers were associated with poorer DFS and CSS ( Fig. 1G and H) .
DISCUSSION
We reported a cohort of 1302 well-characterized consecutive cases of primary operable breast cancer patients, who could be representative of Taiwanese women. These patients were 
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The role of histologic grade in breast cancer treated according to standard protocols in a single institution, with a median follow-up of 30 months. This study was focusing on the clinicopathologic association and prognostic value of histologic grade. The prognostic significance of tumor grade was confirmed in the Taiwanese women from our study. We also found that higher tumor grade was associated with larger tumor size, more positive lymph node metastasis, higher clinical stage at diagnosis, higher HER-2 overexpression, more negative ER and PR expression, higher chemotherapy rate and higher breast cancer death rate. Compared with recently reported grade ratio (Grade I: 18.6 -26.7%, Grade II: 35.6 -37.9% and Grade III: 37.1 -45.6%) (4, 18, 26) , the higher ratio of Grade II (63.5%) breast tumor, the lower Grade III (31.3%) and Grade I (5.2%) tumor were found in our 1302 Taiwanese women with breast cancer. The difference between the previous reported grade ratio and current study may be due to racial difference, different stages at diagnosis and variation between interobservers (27, 28) .
ER expression is clinically relevant to histologic grade in breast cancer. In Table 2 , we could found that 90% Grade I tumor were ER positive and only 44.2% ER-positive rate in Grade III tumor. In ER-negative tumor, 49.2% were Grade III, while in ER-positive tumor only 21.9% were Grade III tumors. ER-negative tumors were associated with higher histologic grade and reported to have higher chemotherapy response rate (26, 29) . However, ER-positive tumors were more heterogeneous in histologic grade and less chemoresponsive (26, 29) . This difference may be reflected in the different disease statuses of ER-positive and ER-negative breast cancers, as supported in gene expression profiling (30) .
HER-2/neu is an oncoprotein and its expression was highly associated with local recurrence, distant metastasis, drug resistance and therefore, a poor prognosis (31 -34) . In our study, 24.8% of patients were HER-2/neu overexpressed cases. In HER-2 positive tumor, 35.1% were Grade III tumor compared with 29.4% in HER-2-negative condition (Table 2) . From our study, higher histologic grade was associated with higher HER-2/neu expression, which was similar to the findings of Lovekin et al. (35) This could partly explain why tumors with a higher histologic grade tend to have a worse prognosis. Except HER-2/neu (c-erbB 2), epidermal growth factor receptor (and HER-1) was also found to have a higher expression in Grade III tumors (24, 36) .
Since the concept of intrinsic subtype introduced (19) (20) (21) (22) , prognostic significance of various subtypes was widely discussed. HER-2 positive subtype was associated the worst prognosis, and luminal A the most fair (25, 37, 38) . In our current intrinsic subtpe classification (24, 25) , TNBC was associated with the most frequent (56.6%) Grade III tumor, followed by HER-2 type (44.3%), then luminal B (29.9.9%) and luminal A (22.3%; P , 0.0001). In Fig. 1C and D, according to various subtypes, the HER-2 positive and TNBC breast cancer patients, which was associated with higher histologic Grade III tumor, had the poorer prognosis compared with luminal B and luminal A patients. These data demonstrated that higher histologic grade was correlated with more invasive breast cancer biologic subtype and therefore poor prognosis (38) .
In recent published 2011 St. Gallen guideline, Ki-67 and/ or histologic grade were incorporated into the classification of breast cancer intrinsic subtypes. In the new definition, luminal B subtype is divided into the ER-and/or PR-positive and HER2-positive subtype, and ER and/or PR-positive, HER2-negative and Ki-67-high (or Grade III) subtype (39) . Due to the lack of Ki-67 data in the study period, Grade III was used as inclusion criteria for luminal B subtype [(ER-positive and/or PR-positive and HER-2-positive) or (ER-positive and/or PR-positive, HER-2-negative and Grade III tumor)]. Then luminal B would be associated with the most frequent Grade III tumor (61.8%), followed by TNBC (56.6%) and HER-2 type (44.3%). While, no Grade III tumor would be found in luminal A (0%) subtype in the new definition of intrinsic subtypes.
As in our multivariate Cox regression analysis, histologic grade was one of the most important prognostic factors regarding breast cancer survival (Table 4) . Although the prognostic importance of histologic grade is well established (1,4,12 -14,16,17,31) , it is not included in the staging criteria defined by the latest AJCC Breast Task Force (40) . One of the main reasons for omitting grade in the staging criteria is the highly correlated interaction between tumor size and lymphatic metastasis, as shown in our study. Tumor stage is a function of tumor size and lymph node metastasis; a higher tumor stage is reasonably associated with a higher histologic grade.
Another limitation of histologic grade is the lack of prognostic information for Grade II tumor. Grade I tumor had favorable outcome, and almost all of them could be done well without chemotherapy. The poor prognosis of patients with Grade III tumor could be used as a mark of poor prognosis and chemotherapy should be indicated in this group of patients ( Fig. 1E and F) . However, for Grade II tumor, which is composed of 30 -60% of all breast cancer (6, 41) , the prognostic significance was not clear. The concept of gene grade index had been used to differentiate Grade II tumor into prognostic well Grade I and poor prognostic Grade III tumor (42) .
The concept of histologic grading was originated in 1925 by Greenough (7) from Europe; 86 years later, it is still proved valid by using modern data analysis in Asia of Taiwan. We showed that histologic grade is a valuable prognostic factor in breast cancer patients of Taiwanese women. Higher histologic tumor grade was associated with larger tumor size, more positive lymph node metastasis, more advanced clinical tumor stage, higher HER-2 positivity, inverse ER and PR expressions. Patients with higher grade of tumor tended to be TNBC or HER-2 subtype, a higher chemotherapy rate and a higher breast cancer death rate.
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